Entera Bio Ltd.
4 private offerings reported to the SEC on Form D since 2016, $297.2M sold in all. Biotech, Israel.
- Form D offerings: 4
- Reported sold: $297.2M
- Newest: Aug 12, 2026
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Aug 12, 2026 | $275.0M | $275.0M | Entera Bio Ltd.Biotech · Israel | Not amended | 0001638097-26-000003 |
| Jan 2, 2024 | $6.6M | $6.6M | Entera Bio Ltd.Biotech · Israel | Not amended | 0001178913-24-000023 |
| Dec 26, 2019 | $13.5M | $13.5M | Entera Bio Ltd.Biotech · Israel | Not amended | 0000950103-19-017690 |
| Oct 19, 2017 | $2.0M | $7.0M | Entera Bio Ltd.Pharma · Israel | Not amended | 0000950103-17-010087 |
SEC Profile
From the company's EDGAR record- Ticker
- ENTX
- Business address
- Jerusalem
- Incorporated in
- Israel
- SEC industry
- Biological Products, (No Diagnostic Substances)
- All SEC filings
- CIK 1638097 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR